Nordic Pharma and Harrow partnered to launch an authorized generic of Maxitrol, Nordic President Philip Gioia said in this Healio Video Perspective from SightLine.Gioia said the neomycin and polymyxin ...

Nordic Pharma, a subsidiary of Nordic Group B.V., announced a partnership with Harrow, a leading North American eyecare ...

to launch an authorized generic of Maxitrol® (Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension), which treats and relieves bacterial eye infections. Maxitrol® and ...

Developed by Venus Medicine Research Centre (VMRC), the R&D division of Venus Remedies, VRP-034 is a novel supramolecular cationic (SMC) formulation of polymyxin B sulphate, uniquely developed to ...

Venus Remedies’ investigational product VRP-034 has been granted Qualified Infectious Disease Product (QIDP) designation by the United States Food and Drug Administration (FDA) for the treatment of ...

India’s Venus Remedies (NSE: VENUSREM) has secured Qualified Infectious Disease Product designation from the US Food and Drug Administration for its investigational antibiotic VRP-034, a ...